Anti-Inflammatory and Anti-Colon Cancer Activities of Mung Bean Grown in Burkina Faso
Table 3
Variation of biochemical parameters observed in rats of different batches (mean ± standard deviation).
Parameters
R1
R2
R3
R4
R5
R6
R7
R8
R9
Htei
37.5a ± 0.5
38.5a ± 0.5
36.5a ± 0.5
34.5a ± 0.5
35.5a ± 0.5
36.00a ± 0.00
34.5a ± 0.5
33.5a ± 0.5
36.5a ± 0.5
Htef
37.5a ± 0.5
19.5b ± 0.5
36.00a ± 0.00
35.5a ± 0.5
37.00a ± 0.00
37.5a ± 0.5
35.00a ± 0.00
34.5a ± 0.5
36.5a ± 0.5
HBi
12.15a ± 0.15
12.85a ± 0.15
10.77a ± 0.55
9.5a ± 0.50
11.31a ± 0.15
10.15a ± 1.14
10.34a ± 0.12
9.45a ± 0.22
11.47a ± 0.14
HBf
11.10b ± 0.10
3.50b ± 0.5
11.32a ± 0.05
10.67a ± 0.47
11.73a ± 0.19
9.5a ± 0.5
11.45a ± 0.13
9.94a ± 0.31
11.44a ± 0.07
GRi
4.12a ± 0.06
4.12a ± 0.15
3.21a ± 0.55
5.28a ± 0.32
5.42a ± 0.21
5.23a ± 0.00
3.87a ± 0.11
4.68a ± 0.46
4.45a ± 0.16
GRf
4.11a ± 0.01
1.16b ± 0.06
3.41a ± 0.02
2.24b ± 0.13
4.45a ± 0.22
4.01a ± 0.00
4.12a ± 0.01
3.65a ± 1.02
4.07a ± 0.06
GBi
5.22a ± 0.10
6.00a ± 0.39
2.93b ± 0.27
3.44a ± 0.48
4.26a ± 0.03
6.28a ± 0.95
3.45a ± 0.22
4.67a ± 0.49
4.16a ± 0.03
GBf
3.54b ± 0.11
1.77b ± 0.54
4.31a ± 0.06
5.83a ± 0.40
3.89a ± 0.37
5.02a ± 0.09
3.48a ± 0.34
4.29a ± 0.17
4.26a ± 0.07
Li
23.5a ± 4.5
20.5b ± 0.5
17.00a ± 1.00
17.00a ± 1.00
18.00a ± 0.00
17.00a ± 0.00
23.5a ± 1.5
18.00a ± 2.00
19.5a ± 0.5
Lf
21.5a ± 1.5
43.00a ± 4
20.5a ±.05
20.00a ± 0.00
17.5a ± 1.5
21.5a ± 0.5
24.5a ± 1.5
20.5a ± 1.5
19.5a ± 0.5
Ni
40.00a ± 0.00
40.5b ± 1.5
27.5b ± 1.5
42.00a ± 3.00
64.00a ± 1.00
33.00a ± 4.00
34.00a ± 5.00
40.5a ± 1.5
41.5a ± 0.5
Nf
40.00a ± 0.00
87.5a ± 5.5
41.00a ± 1.00
56.5a ± 28.5
66.00a ± 1.00
54.5a ± 5.5
40.5a ± 0.5
39.5a ± 0.5
42.00a ± 0.00
Ureai
0.42a ± 0.01
0.33b ± 0.04
0.19a ± 0.03
0.19a ± 0.01
0.14a ± 0.01
0.19a ± 0.04
0.55a ± 0.42
0.36a ± 0.17
0.38a ± 0.02
Ureaf
0.39a ± 0.03
3.87a ± 0.11
0.20a ± 0.04
0.25a ± 0.08
0.38a ± 0.19
1.16a ± 0.04
0.21a ± 0.02
0.16a ± 0.01
0.41a ± 0.00
ASTi
96a ± 4
100.00b ± 2
120.5a ± 12
117.5a ± 6.5
118.5a ± 0.5
103.00b ± 1.00
86.5b ± 2.5
163.00a ± 1.00
104.5a ± 1.5
ASTf
105a ± 1
356.00a ± 47
122.5a ± 0.5
97.00b ± 1.00
87.00b ± 9.00
129.00a ± 3.00
109.5a ± 0.5
128.00b ± 3.5
107.00a ± 2.00
ALTi
101a ± 1
81.00b ± 17
92.5a ± 3.5
88.00b ± 2.00
120.5a ± 2.5
125.5a ± 2.5
116.00a ± 2.00
127.00a ± 5.00
106.00a ± 2.00
ALTf
96a ± 2
256.00a ± 8
75.5a ± 13.5
98.5a ± 0.5
113.00a ± 11.00
113.00b ± 1.00
115.00a ± 19.00
107.5b ± 4.5
101.5a ± 1.5
Creati
7.55a ± 0.35
9.47b ± 0.23
7.38a ± 0.42
7.24a ± 0.9
11.31a ± 3.91
8.21a ± 0.12
7.1a ± 0.2
8.75a ± 0.15
7.17a ± 0.07
Creatf
8.40a ± 0.20
15.23a ± 1.9
8.43a ± 0.81
6.38a ± 0.7
5.25b ± 0.65
10.68a ± 0.55
7.7a ± 0.5
9.80a ± 2.20
7.15a ± 0.03
R1: negative control; R2: DMH treatment; R3: inhibition effect of MBN extracts; R4: inhibition effect of MBG extracts; R5: curative effect of MBN extracts; R6: curative effect of MBG extracts; R7: preventive effect of MBN extracts; R8: preventive effect of MBG extracts; R9: effects of 5-fluorouracil used as reference molecule. Intra-column means followed by the different letters differ significantly at the 5% level for each constituted batch. Htei: initial hematocrit level; Htef: final hematocrit level; HBi: initial hemoglobin level; HBf: final hemoglobin level; GRi: initial red cell count; GRf: final red cell count; GBi: initial white blood cell count; GBf: final white blood cell count; Li: initial leukocyte; Lf: final leukocyte; Ni: initial neutrophils; Nf: final neutrophils; Ureai: initial uremia; Ureaf: final uremia; ASTi: initial aspartate aminotransferase; ASTf: final aspartate aminotransferase; ALTi: initial alanine aminotransferase; ALTf: final alanine aminotransferase; Creati: initial creatinine; Creatf: final creatinine.
